ストックスクリーナーアプリを入手
0.9401
1.62%
0.015
アフターアワーズ：
.92
-0.0201
-2.14%
前日終値:
$0.9251
開ける：
$0.925
24時間の取引高:
61,043
Relative Volume:
0.41
時価総額：
$15.52M
収益：
-
当期純損益:
$-10.58M
株価収益率:
-0.6352
EPS:
-1.48
ネットキャッシュフロー:
$-9.21M
1週間 パフォーマンス:
-1.07%
1か月 パフォーマンス:
+4.33%
6か月 パフォーマンス:
-4.05%
1年 パフォーマンス:
-33.80%
1日の値動き範囲:
$0.9211
$0.9544
1週間の範囲:
$0.9211
$0.985
52週間の値動き範囲:
$0.82
$2.3499
Microbot Medical Inc Stock (MBOT) Company Profile
名前
Microbot Medical Inc
セクター
電話
908-938-5561
住所
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-01-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-31 | 開始されました | Ladenburg Thalmann | Buy |
Microbot Medical Inc (MBOT) 最新ニュース
Microbot Medical Releases Investor Presentation Materials - TipRanks
Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com
Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance
Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex
Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia
Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network
Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News
Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com
Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks
Microbot Medical Announces the Successful Completion of its - GlobeNewswire
Microbot Medical faces Nasdaq delisting over share price - Investing.com India
Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Microbot Medical nears end of pivotal clinical trial - Investing.com
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network
Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks
Microbot Medical Inc. Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial - Marketscreener.com
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian
Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan
Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
MicroAlgo receives Nasdaq minimum bid price warning - Investing.com
MicroAlgo Faces Nasdaq Minimum Price Warning - TipRanks
MLGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for MicroAlgo Inc (MLGO) - The Dwinnex
The Wild Robot giveaway - Lyles Movie Files
Pedro Pascal and Lupita Nyong’o starrer The Wild Robot to release in Indian theatres on October 18 - Bollywood Hungama
Win Advance Screening Passes to THE WILD ROBOT in Florida - FlickDirect, Your Premiere Source For Movies And Entertainment!
Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks
Microbot Medical (NASDAQ:MBOT) & Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Review - Defense World
OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK
The Wild Robot- Chicago – Advance Screening - The Movie Blog
Microbot Medical Advances in Endovascular Robotic Trials - TipRanks
Microbot Medical Announces the Successful Enrollment of 50% - GlobeNewswire
Microbot Medical Inc. Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Marketscreener.com
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Yahoo Finance
Microbot Medical Stock Is Moving Higher: What's Going On? - MSN
Microbot Medical Shares Investor Presentation Update - TipRanks
Trial Enrollment For LIBERTY Robotic Surgical System Reaches Midpoint - MPO-mag
MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com
Market Resilience: Microbot Medical Inc (MBOT) Finishes Weak at 0.88, Down -4.35 - The Dwinnex
THINK Surgical scoops additional FDA 510(k) clearance on Tmini surgical robot - Medical Device Network
Microbot Medical, Emory University To Consider LIBERTY Robotic System Partnership - MPO-mag
Microbot Medical advances Liberty Robotic System telesurgery innovation - Yahoo Finance
Microbot Medical, Emory University to Consider LIBERTY Robotic System Partnership - MPO-mag
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - MSN
Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation - Medical Device Network
Microbot Medical advances telesurgery with new phase - Investing.com India
Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com Canada
Examining MBOT’s book value per share for the latest quarter - US Post News
Microbot Medical Inc (MBOT) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
5.88%
大文字化:
|
ボリューム (24 時間):